ClinConnect ClinConnect Logo
Search / Trial NCT01801566

Effectiveness of the Single Implant-retained Mandibular Overdenture Treatment

Launched by UNIVERSIDADE FEDERAL DE GOIAS · Feb 28, 2013

Trial Information

Current as of June 17, 2025

Completed

Keywords

Mandibular Prosthesis Implantation Prostheses And Implants Denture, Complete, Lower

ClinConnect Summary

This study is a longitudinal evaluation of clinical and patient-reported outcomes related to the single-implant mandibular overdenture treatment. Sixty completely edentulous individuals will be included. First, new complete dentures will be fabricated for all of them. Panoramic radiographs and conventional tomograms of the mandibular midline region will be obtained in order to plan the implant placement surgery. After the adaptation period related to the use of the new dentures, a single implant (Titamax IT Cortical, Neodent, Curitiba, Brazil) will be installed in the mandibular midline of ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Fully edentulous patients
  • Need of replacement of the mandibular denture or patient without mandibular denture
  • Patients with poor adaptation to the mandibular denture
  • Patients with good general health
  • Exclusion Criteria:
  • Patients who refuse to receive a conventional dentures opposed to a mandibular overdenture retained by a single implant
  • Patients with local intraoral diseases that influence denture stability, retention and adaptation of the lower denture (such as changes or anatomical deformations of the jaws, mucosal changes caused by fungi and bacteria, tumor changes and absolute xerostomia)
  • Patients with systemic, psychological or neurological diseases that preclude or hinder oral movements of the patient for clinical care and/or clinical follow-up in all stages of the research
  • Patients who choose other treatment modalities not covered by the study
  • Patients with alcoholism or other severe behavioral disorders that compromise their participation in the study

About Universidade Federal De Goias

The Universidade Federal de Goiás (UFG) is a prominent Brazilian higher education institution renowned for its commitment to advancing research and healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UFG aims to enhance medical knowledge and improve patient outcomes by conducting rigorous, ethical studies across various therapeutic areas. The university fosters a research environment that combines academic excellence with community engagement, ensuring that its clinical trials not only contribute to scientific advancement but also address pressing health challenges faced by diverse populations.

Locations

Goiania, Goias, Brazil

Patients applied

0 patients applied

Trial Officials

Claudio R Leles, DDS, PhD

Principal Investigator

Universidade Federal de Goias

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials